Eylea 8mg: Injections that save vision

Eylea 8mg: Injections that save vision

Promedica Ophthalmology has taken its first step in implementing the latest therapy Eylea 8mg, an advanced drug for the treatment of retinological diseases. Today, Dr. Zlatko Chipurovski administered this revolutionary new drug to two patients, which represents a significant moment for our hospital.

What is Eylea 8mg and who is it for?

Eylea 8mg is the latest version of this already well-known and proven drug that is used to treat retinological eye conditions such as wet macular degeneration and diabetic retinopathy. These conditions often lead to significant vision loss if not treated properly and promptly. Eylea 8mg is intended for patients who are facing these diseases and are looking for an effective treatment that provides long-term protection of their vision.

How does Eylea 8mg work?

Compared to Eylea, the drug that we have been administering to patients for years, Eylea 8mg differs in that it has a higher concentration, which allows for less frequent application. Patients can get longer-lasting protection with fewer injections, making treatment more comfortable and effective. This drug works by blocking proteins that cause abnormal blood vessel growth in the eye, thereby preventing damage to the retina and improving or stabilizing vision.

Application in Promedica Ophthalmology

Today’s application of Eylea 8mg by Dr. Zlatko Chipurovski is an important step in Promedika Ophthalmology’s efforts to provide cutting-edge therapies to its patients. This advancement not only improves the quality of life of patients, but also positions our services as a leader in ophthalmology.

We are proud to offer our patients access to the latest medical advances and will continue to invest in their care and health.

Promediкa Ophthalmology introduced the first and most modern laser in the country for retinological diseases

Promediкa Ophthalmology introduced the first and most modern laser in the country for retinological diseases

The most modern laser in the country for retinological diseases

Promedica Ophthalmology proudly introduces the Easyret 577 nm yellow laser, a revolutionary technology for the treatment of patients with retinal diseases. We are the only hospital in the country to introduce this laser, and it will be able to treat patients with retinological conditions such as diabetic retinopathy, cystoid macular edema, and deep inflammation in the eye.
 
This laser is a complement to anti-VEGF therapy, it works by stimulating cells, helping them to regenerate and regain their normal function, without damaging the tissue or leaving laser marks. Also, Easyret 577 nm is a new hope for patients who cannot be treated with anti-VEGF therapy and expands the list of diseases that can be treated in our country.
 
With Easyret 577 nm, patients receive a safer and less invasive treatment, with significantly improved chances of recovery. At Promedica Ophthalmology, we continue to lead the development of modern technologies in ophthalmology, providing the best possible solutions for our patients.
 
With this laser, we prove once again that Promedika Ophthalmology is always in step with modern technologies in the world and at the same time a leader in the country.

“Payment in installments” benefit

“Payment in installments” benefit

What does the "payment in installments" benefit mean?

With our “installment payment” benefit, you can now have the intervention you need and pay for it later. The participant/patient is required to pay 30% of the total amount no later than the day of the intervention, and the remaining 70% of the total amount is distributed in 10 equal monthly installments. This offer is valid for all interventions and can be used by all patients who have difficulty paying.

The “installment payment” benefit is 0% interest, simple, fast and without any additional or hidden costs. Also, the benefit does not involve a bank nor will you need to fill out any bank forms or pay any bank fees and costs.

All patients who are interested in taking advantage of this benefit will have the opportunity to have the examination and the intervention itself on the same day.

How can I take advantage of this benefit?

If you are interested in having any of the interventions performed and taking advantage of the “payment in installments” benefit, you can contact us at 071 301 301. Our team will provide you with all the necessary information and guide you through the entire procedure, so that you can get the clear vision you deserve with the help of our flexible benefit.

The Promediкa Ophthalmology team participates in “ESCRS 2024”

The Promediкa Ophthalmology team participates in “ESCRS 2024”

Our team participated in the 42nd ESCRS 2024 Congress, which was held in Barcelona, ​​Spain, starting on September 6th and lasting four days. Our eye hospital was represented by Dr. Naum Trpenoski, Dr. Ivana Pekovska, Dr. Kristina Shisharica.One of the mentors at this prestigious congress was Assoc. Prof. Dr. Biljana Kostovska, who imparted to the participants the key surgical skills and knowledge necessary for a successful career in cataract surgery.

Department of Pediatric Ophthalmology and Strabology: Promedica Ophthalmology always in step with world trends

Department of Pediatric Ophthalmology and Strabology: Promedica Ophthalmology always in step with world trends

At Promedika Ophthalmology, we are always up to date with the latest trends and innovations in the field of ophthalmology. Our commitment to constantly upgrading our knowledge and skills makes us a leading eye hospital offering the best patient care in the country, as well as in other areas, including the treatment of pediatric ophthalmology and strabology.

Promedica Ophthalmology is constantly working on improving and further training its ophthalmologists, in order to keep up with global trends and the latest treatment methods so that we can offer the best to our patients. As proof of this, Dr. Viktorija Fileva Fotevska, As an ophthalmologist at our hospital, who heads the Department of Pediatric Ophthalmology and Strabology, he is currently participating in an international workshop and lecture to further enhance his knowledge and skills. The lecture was given by Dr. Kenneth Wright.

We not only follow, but also actively apply the latest trends and treatment methods. Dr. Viktorija Fileva Fotevska’s participation in these prestigious trainings is part of our commitment to providing the best care for our patients.

Promedica Ophthalmology is the largest group of eye hospitals in the region and cooperates with the following companies.

Dr. Ivana Petkovska participated in retinal surgery education in Switzerland.

Д-р Ивана Петковска учествуваше на едукација за хирургија на ретина во Швајцарија

From 04-05.04.2025, Dr. Ivana Petkovska from Promedika Ophthalmology participated in a retinal surgery course, organized in collaboration with Bausch & Lomb. The course was held at the ESASO training center in Lugano, Switzerland, where experiences and new methods for the treatment of diabetic retinopathy, macular degeneration and retinal holes were exchanged.

By participating in this course, Dr. Petkovska improved her expertise in applying the latest technological innovations in ophthalmic surgery and continues to raise the standards of Promedika Ophthalmology.